{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:11:59Z","timestamp":1791112319830,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0141","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T07:24:48Z","timestamp":1027668288000},"page":"401-436","source":"Crossref","is-referenced-by-count":152,"title":["Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management"],"prefix":"10.1053","volume":"14","author":[{"given":"Jan Jacques","family":"Michiels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"van der Planken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huub H.D.M.","family":"van Vliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Schroyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zwi","family":"Berneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0141_RF1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0950-3536(98)80051-6","article-title":"Acquired von Willebrand disease","volume":"11","author":"Van Genderen","year":"1998","journal-title":"Baill\u00e8re's Clinical Haematology"},{"key":"10.1053\/beha.2001.0141_RF2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine"},{"key":"10.1053\/beha.2001.0141_RF4","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"Sadler","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0889-8588(18)30283-1","article-title":"Acquired von Willebrand's disease","volume":"6","author":"Jakway","year":"1992","journal-title":"Hematology and Oncology Clinics of North America"},{"key":"10.1053\/beha.2001.0141_RF6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1096-8652(199702)54:2<139::AID-AJH7>3.0.CO;2-Y","article-title":"Acquired von Willebrand's disease","volume":"54","author":"Rinder","year":"1997","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0002-9343(97)00239-8","article-title":"Acquired von Willebrand disease: concise review of occurrence, diagnosis, pathogenesis, and treatment","volume":"103","author":"Tefferi","year":"1997","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2007-996119","article-title":"Acquired von Willebrand disease in patients with high platelet counts","volume":"23","author":"Budde","year":"1997","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF9","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1182\/blood.V91.10.3623","article-title":"Clinical significance of inhibitors in acquired von Willebrand syndrome","volume":"91","author":"Mohri","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1365-2516.1999.00340.x","article-title":"Acquired von Willebrand syndrome: report of 10 cases and review of the literature","volume":"5","author":"Nitu-Whalley","year":"1999","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0141_RF11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0037-1613993","article-title":"Acquired von Willebrand syndrome: from pathophysiology to management","volume":"84","author":"Veyradier","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1055\/s-0037-1614018","article-title":"Acquired von Willebrand syndrome: data from an International Registry","volume":"84","author":"Federici","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","article-title":"Recessive inheritance of von Willebrand's disease type I","volume":"341","author":"Eikenboom","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(87)92272-0","article-title":"Hypothyroidism as a cause of acquired von Willebrand's disease","volume":"1","author":"Dalton","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF15","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1055\/s-0038-1646064","article-title":"Acquired von Willebrand's disease in hypothyroidism","volume":"58","author":"Takahashi","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0140-6736(87)90565-4","article-title":"Hypothyroidism and von Willebrand's disease","volume":"1","author":"Smith","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF17","first-page":"314","article-title":"Hypothyroidism and von Willebrand's disease","volume":"I","author":"MacCallum","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/pgmj.66.776.474","article-title":"Acquired von Willebrand's disease and hypothyroidism: report of a case presenting with menorrhagia","volume":"66","author":"Blesing","year":"1990","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beha.2001.0141_RF19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0197-0070(91)90459-Y","article-title":"Hypothyroidism and acquired von Willebrand disease","volume":"12","author":"Coccia","year":"1991","journal-title":"Journal of Adolescent Health"},{"key":"10.1053\/beha.2001.0141_RF20","first-page":"284","article-title":"Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism","volume":"2","author":"Levesque","year":"1993","journal-title":"European Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0022-3476(05)82007-4","article-title":"Acquired von Willebrand disease in twins with autoimmune hypothyroidism: response to desmopressin and l-thyroxine therapy","volume":"125","author":"Bruggers","year":"1994","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0141_RF22","first-page":"91","article-title":"A patient with postpartum primary hypothyroidism and acquired von Willebrand's disease","volume":"44","author":"Tjan-Heijnen","year":"1994","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajh.2830500311","article-title":"Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis","volume":"50","author":"Aylesworth","year":"1995","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1056\/NEJM196511112732001","article-title":"Blood coagulation in thyroid dysfunction","volume":"273","author":"Simone","year":"1965","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF25","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.218285","article-title":"Thyroid hormone action at the cellular level","volume":"203","author":"Oppenheimer","year":"1979","journal-title":"Science"},{"key":"10.1053\/beha.2001.0141_RF26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0022-3476(79)80293-0","article-title":"Acquired von Willebrand disease in a patient with Wilms tumor","volume":"95","author":"Noronha","year":"1979","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0141_RF27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/blood.V58.4.665.665","article-title":"Acquired von Willebrand's disease in association with Wilms' tumor: regression following treatment","volume":"58","author":"Scott","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ajh.2830240304","article-title":"Platelet dysfunction with Wilms tumor and hyaluronic acid","volume":"24","author":"Bracey","year":"1987","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF29","first-page":"253","article-title":"Wilms' tumour with acquired von Willebrand's disease","volume":"23","author":"Han","year":"1987","journal-title":"Australian Paediatric Journal"},{"key":"10.1053\/beha.2001.0141_RF30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1200\/JCO.1992.10.3.422","article-title":"Acquired von Willebrand disease in Wilms' tumor patients","volume":"10","author":"Coppes","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2001.0141_RF31","first-page":"422","article-title":"Acquired von Willebrand's disease in children with Wilms tumor","volume":"10","author":"Jonge Paerink-Stocksch\u00e4der","year":"1992","journal-title":"Medical Pediatric Oncology"},{"key":"10.1053\/beha.2001.0141_RF32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1182\/blood.V31.6.806.806","article-title":"Acquired von Willebrand's syndrome in systemic lupus erythematosus","volume":"31","author":"Simone","year":"1968","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1971.tb03429.x","article-title":"Four cases of acquired von Willebrand's syndrome","volume":"21","author":"Ingram","year":"1971","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF34","first-page":"7","article-title":"Acquired von Willebrand's syndrome and systemic lupus erythematosus","volume":"65","author":"Poole-Wilson","year":"1972","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1053\/beha.2001.0141_RF35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajh.2830050411","article-title":"Antibody-induced von Willebrand syndrome","volume":"5","author":"Gazengel","year":"1978","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF36","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1055\/s-0038-1657054","article-title":"Acquired von Willebrand's syndrome during autoimmune disorder","volume":"42","author":"Pizzuto","year":"1979","journal-title":"Thrombosis and Haemostatis"},{"key":"10.1053\/beha.2001.0141_RF37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-9343(88)90607-9","article-title":"Development of acquired von Willebrand's disease after mixed connective tissue disease","volume":"85","author":"Yoshida","year":"1988","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00043426-198921000-00008","article-title":"Acquired von Willebrand's syndrome with lupus-like serology","volume":"11","author":"Igarashi","year":"1989","journal-title":"American Journal of Pediatric Hematology and Oncology"},{"key":"10.1053\/beha.2001.0141_RF39","first-page":"424","article-title":"Autoantibody to von Willebrand factor in systemic lupus erythematosus","volume":"121","author":"Soff","year":"1993","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1053\/beha.2001.0141_RF40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajh.2830460216","article-title":"Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin","volume":"46","author":"Hanley","year":"1994","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF41","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2141.1999.01360.x","article-title":"Three cases of acquired von Willebrand disease associated with systemic lupus erythematosus","volume":"105","author":"Viallard","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V82.6.1749.1749","article-title":"Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma","volume":"82","author":"Budde","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF43","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x","article-title":"The reduction of large von Willebrand factor multimers in patients with essential thrombocythemia is related to the platelet count","volume":"93","author":"Van Genderen","year":"1996","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/107602969900500301","article-title":"Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia","volume":"5","author":"Michiels","year":"1999","journal-title":"Clinical and Applied Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.V42.3.429.429","article-title":"Von Willebrand's syndrome presenting as an acquired bleeding disorder in association with a monoclonal gammopathy","volume":"42","author":"Mant","year":"1973","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1365-2141.1974.tb06676.x","article-title":"von Willebrand factor and ristocetin","volume":"28","author":"Meyer","year":"1974","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9343(78)90698-8","article-title":"Acquired von Willebrand's disease, platelet-release defect and angiodysplasia","volume":"65","author":"Rosborough","year":"1978","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.V54.3.600.600","article-title":"Selective absence of large forms of factor VIII\/von Willebrand factor in acquired von Willebrand's syndrome","volume":"54","author":"Meyer","year":"1979","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF49","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1136\/jcp.32.10.1030","article-title":"Acquired von Willebrand's syndrome with IgM inhibitor against von Willebrand's factor","volume":"32","author":"Gouault-Heilman","year":"1979","journal-title":"Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF50","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.0954-6820.1978.tb08484.x","article-title":"Acquired von Willebrand's disease caused by a monoclonal antibody","volume":"204","author":"Zetterval","year":"1978","journal-title":"Acta Medica Scandinavica"},{"key":"10.1053\/beha.2001.0141_RF51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ajh.2830090403","article-title":"Pathogenesis of antibody-induced acquired von Willebrand syndrome","volume":"9","author":"Gan","year":"1980","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF52","first-page":"2171","article-title":"D\u00e9ficit acquis de facteur Willebrand associ\u00e9 \u00e0 une gammapathie monoclonale IgG kappa","volume":"10","author":"Sitbon","year":"1981","journal-title":"Nouvelle Presse M\u00e9dicale"},{"key":"10.1053\/beha.2001.0141_RF53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/pgmj.58.675.37","article-title":"Angiodysplasia of the tongue with acquired von Willebrand's disease","volume":"58","author":"Wood","year":"1982","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beha.2001.0141_RF54","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2141.1983.tb02091.x","article-title":"Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases","volume":"54","author":"Sampson","year":"1983","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF55","first-page":"707","article-title":"Quatre cas de deficit acquis en facteur Willebrand associ\u00e9s a une dysgubulin\u00e9mie monoclonale","volume":"143","author":"Horellou","year":"1983","journal-title":"Annales de Medecine Interne"},{"key":"10.1053\/beha.2001.0141_RF56","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.V64.3.614.614","article-title":"Studies on the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies","volume":"64","author":"Mannucci","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF57","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1182\/blood.V66.3.562.562","article-title":"Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand binding by antibody","volume":"66","author":"Fricke","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF58","first-page":"143","article-title":"The use of high-dose intravenous gammaglobulin in acquired von Willebrand syndrome","volume":"112","author":"Macik","year":"1988","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"10.1053\/beha.2001.0141_RF59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1055\/s-0038-1645964","article-title":"Abnormal structure of von Willebrand factor in myeloproliferative syndrome is associated to either thrombotic or bleeding diathesis","volume":"58","author":"Lopez-Fernandez","year":"1987","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF60","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/pgmj.63.744.901","article-title":"Prolonged post-operative bleeding due to an acquired von Willebrand syndrome","volume":"63","author":"Kinsey","year":"1987","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beha.2001.0141_RF61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2141.1988.tb02502.x","article-title":"High-dose intravenous gammaglobulin for acquired von Willebrand's disease","volume":"70","author":"Delannoy","year":"1988","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2141.1988.tb06194.x","article-title":"Acquired type II von Willebrand's disease: demonstration of a complexed inhibitor of the von Willebrand factor\u2013platelet interaction and response to treatment","volume":"68","author":"Goudemand","year":"1988","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF63","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF00320776","article-title":"Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy","volume":"58","author":"Castaman","year":"1989","journal-title":"Blut"},{"key":"10.1053\/beha.2001.0141_RF64","first-page":"504","article-title":"Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia","volume":"26","author":"Rhamani","year":"1990","journal-title":"Israeli Journal of Medical Sciences"},{"key":"10.1053\/beha.2001.0141_RF65","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/pgmj.66.777.560","article-title":"Acquired von Willebrand's disease associated with free lambda light chain monoclonal gammopathy, normal bleeding time and response to prednisolone","volume":"66","author":"Stewart","year":"1990","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beha.2001.0141_RF66","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830410212","article-title":"Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate","volume":"41","author":"Castaman","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/ajh.2830400214","article-title":"Acquired von Willebrand's disease: correction of hemostatic defect by high dose intravenous immunoglobulins","volume":"40","author":"Delmer","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF68","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1993.tb03103.x","article-title":"Expression of GPIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand's disease","volume":"84","author":"Scrobohaci","year":"1993","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2141.1993.tb03074.x","article-title":"Gastrointestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immunoglobulin where substitution treatments failed","volume":"84","author":"White","year":"1993","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF70","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood.V84.10.3378.3378","article-title":"Acquired von Willebrand disease caused by an auto-antibody selectively inhibiting the binding of von Willebrand factor to collagen","volume":"84","author":"Van Genderen","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1423-0410.1994.tb05030.x","article-title":"Effectiveness of high-dose intravenous gammaglobulin therapy in acquired von Willebrand's disease","volume":"67","author":"Van Genderen","year":"1994","journal-title":"Vox Sanguinis"},{"key":"10.1053\/beha.2001.0141_RF72","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/pgmj.70.830.916","article-title":"High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease","volume":"70","author":"Van Genderen","year":"1994","journal-title":"Postgraduate Medical Journal"},{"key":"10.1053\/beha.2001.0141_RF73","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1055\/s-0038-1653887","article-title":"High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease","volume":"73","author":"Van Genderen","year":"1995","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0248-8663(96)88123-9","article-title":"Association maladie de Willebrand acquise gammapathy monoclonal\u2013angiodysplasie du gr\u00eale: une indication rare des immunoglobulines intraveineuses \u00e0 forte dose","volume":"17","author":"Sailler","year":"1996","journal-title":"Revue de Medecine Interne"},{"key":"10.1053\/beha.2001.0141_RF75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0609.1998.tb01038.x","article-title":"Intravenous gammaglobulin therapy for acquired von Willebrand disease","volume":"60","author":"Van de Bosch","year":"1998","journal-title":"European Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF76","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1182\/blood.V92.8.2707","article-title":"Treatment of acquired von Willebrand syndrome in patients with monoclonal gammapathy of uncertain significance: comparison of three different therapeutic approaches","volume":"92","author":"Federici","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ajh.2830220412","article-title":"DDAVP in acquired von Willebrand syndrome associated with multiple myeloma","volume":"22","author":"Takahashi","year":"1986","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF78","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2141.1992.tb04610.x","article-title":"Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopedic surgery","volume":"82","author":"Gross","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ajcp\/85.1.115","article-title":"A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor","volume":"85","author":"Bovill","year":"1986","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF80","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/ajcp\/87.5.663","article-title":"Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor","volume":"87","author":"Mohri","year":"1987","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF81","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ajcp\/92.4.471","article-title":"Absence of a bleeding tendency in severe acquired von Willebrand's disease","volume":"92","author":"Drouin","year":"1989","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF82","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/bjs.1800670910","article-title":"Gastrointestinal bleeding, angiodysplasia of the colon and acquired von Willebrand's disease","volume":"67","author":"Cass","year":"1980","journal-title":"British Journal of Surgery"},{"key":"10.1053\/beha.2001.0141_RF83","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2141.1992.tb03005.x","article-title":"Acquired von Willebrand's disease due to excessive fibrinolysis","volume":"81","author":"Eikenboom","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-0038-1650099","article-title":"Acquired von Willebrand's syndrome in the course of Waldenstr\u00f6m's disease","volume":"44","author":"Mazurier","year":"1980","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF85","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1537-2995.1987.27387235627.x","article-title":"The efficacy of intensive plasma exchange in acquired von Willebrand's disease","volume":"27","author":"Silberstein","year":"1987","journal-title":"Transfusion"},{"key":"10.1053\/beha.2001.0141_RF86","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-0609.1976.tb01127.x","article-title":"Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukemia","volume":"16","author":"Wautier","year":"1976","journal-title":"Scandinavian Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF87","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1537-2995.1991.31391165179.x","article-title":"Immunoadsorption for coagulation factor inhibitors","volume":"31","author":"Uelinger","year":"1991","journal-title":"Transfusion"},{"key":"10.1053\/beha.2001.0141_RF88","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archotol.1991.01870130112028","article-title":"Acquired von Willebrand's syndrome","volume":"117","author":"Brownlee","year":"1991","journal-title":"Archives of Otolaryngology and Head and Neck Surgery"},{"key":"10.1053\/beha.2001.0141_RF89","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V48.3.393.393","article-title":"Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome","volume":"48","author":"Handin","year":"1976","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF90","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM197805042981802","article-title":"Acquired von Willebrand's disease: evidence for a quantitative and qualitative factor VIII disorder","volume":"298","author":"Joist","year":"1978","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF91","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.1985.tb02830.x","article-title":"Profound alterations of the multimeric structure of von Willebrand factor in a patient with malignant lymphoma","volume":"61","author":"Tran-Thangh","year":"1985","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2141.1987.tb06141.x","article-title":"Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor","volume":"65","author":"Ball","year":"1987","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF93","first-page":"47","article-title":"Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma","volume":"112","author":"Rao","year":"1988","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"10.1053\/beha.2001.0141_RF94","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0609.1979.tb00424.x","article-title":"Acquired von Willebrand's syndrome and Ehlers\u2013Danlos syndrome presenting with gastrointestinal bleeding","volume":"22","author":"Clough","year":"1979","journal-title":"Scandinavian Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF95","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2141.1980.tb03821.x","article-title":"Acquired von Willebrand's syndrome","volume":"45","author":"Holland","year":"1980","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF96","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9343(79)90267-5","article-title":"Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangectasia","volume":"67","author":"McGrath","year":"1979","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.2830270211","article-title":"Prolonged remission after life-threatening gastrointestinal hemorrhage from coexistent angiodysplasia and acquired bleeding diathesis","volume":"27","author":"Woodlock","year":"1988","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-1987.x","article-title":"Acquired von Willebrand disease in a patient with angiodysplasia resulting from immune-mediated clearance of von Willebrand factor","volume":"96","author":"Inbal","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF99","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0038-1661144","article-title":"Acquired von Willebrand's syndrome associated with hydatid disease of the spleen","volume":"52","author":"Richard","year":"1984","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mpo.2950250213","article-title":"Acquired von Willebrand disease in malignant peripheral neurectodermal tumor","volume":"25","author":"Nowak-G\u00f6ttl","year":"1995","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2001.0141_RF101","first-page":"211","article-title":"Acquired von Willebrand's disease following bone marrow transplantation","volume":"24","author":"Lazarchik","year":"1994","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1053\/beha.2001.0141_RF102","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-3476(05)82413-8","article-title":"Acquired von Willebrand disease after Epstein\u2013Barr virus infection","volume":"119","author":"Kinoshita","year":"1991","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beha.2001.0141_RF103","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/107602969900500302","article-title":"Acquired von Willebrand disease in monoclonal gammopathies: effectiveness of high-dose intravenous gammaglobulin","volume":"5","author":"Michiels","year":"1999","journal-title":"Clinical and Applied Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM197902223000806","article-title":"A hemorrhagic syndrome in Waldenstr\u00f6m's macroglobulinemia secondary to immunoadsorption of factor VIII","volume":"300","author":"Brody","year":"1979","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0141_RF105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1980.tb06001.x","article-title":"Acquired von Willebrand's syndrome associated with hairy cell leukemia","volume":"46","author":"Roussi","year":"1980","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.2830350210","article-title":"Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells","volume":"35","author":"Richard","year":"1990","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF107","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.1992.tb04562.x","article-title":"Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma","volume":"80","author":"Facon","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF108","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1365-2141.1997.d01-2088.x","article-title":"Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells","volume":"96","author":"Tefferi","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF109","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1182\/blood.V83.8.2171.2171","article-title":"Shear stress enhances the proteolysis of von Willebrand factor in normal plasma","volume":"83","author":"Tsai","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V67.3.758.758","article-title":"Loss of the largest von Willebrand factor multimers from plasma of patients with congenital cardiac defects","volume":"67","author":"Gill","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0038-1647035","article-title":"von Willebrand factor and mitral valve prolapse","volume":"60","author":"Froom","year":"1988","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0141_RF112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0140-6736(92)92434-H","article-title":"Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link?","volume":"340","author":"Warkentin","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF113","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0140-6736(92)92155-9","article-title":"Heart valve stenosis and von Willebrand's factor multimers","volume":"340","author":"O'Brien","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF114","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(96)91240-4","article-title":"Reversal of aortic stenosis, bleeding and von Willebrand syndrome by aortic valve replacement","volume":"347","author":"Anderson","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF115","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/ajcp\/93.3.395","article-title":"Abnormality of von Willebrand factor in patients with hemoglobin E-\u03b2 thalassemia","volume":"93","author":"Benson","year":"1990","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF116","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0049-3848(90)90417-B","article-title":"Qualitative and quantitative abnormalities of von Willebrand antigen in patients with diabetes mellitus","volume":"59","author":"Pasi","year":"1990","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0141_RF117","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1172\/JCI111628","article-title":"Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation","volume":"74","author":"Federici","year":"1984","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0141_RF118","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1987","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF119","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ajh.2830260204","article-title":"Acquired von Willebrand disease in patients with polycythemia vera","volume":"26","author":"Mohri","year":"1987","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF120","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1600-0609.1986.tb01738.x","article-title":"Unique multimeric pattern of von Willebrand factor in patients with benign monoclonal gammopathy","volume":"36","author":"Lopez-Fernandez","year":"1986","journal-title":"Scandinavian Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF121","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2257.1988.tb01190.x","article-title":"Multimeric composition of plasma von Willebrand factor in chronic myeloproliferative disorders","volume":"10","author":"Tatewaki","year":"1988","journal-title":"Clinical and Laboratory Haematology"},{"key":"10.1053\/beha.2001.0141_RF122","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ajh.2830490406","article-title":"Platelet von Willebrand factor in myeloproliferative syndromes","volume":"49","author":"Castaman","year":"1995","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF123","first-page":"713","article-title":"H\u00e4mostasest\u00f6rung mit verminderter Aktivit\u00e4t des von Willebrand-Faktors bei myeloproliferativen Syndromen","volume":"113","author":"Leupin","year":"1983","journal-title":"Schweitzerische Medizinische Wochenschrift"},{"key":"10.1053\/beha.2001.0141_RF124","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ajcp\/88.1.102","article-title":"Essential thrombocythemia with acquired von Willebrand's disease","volume":"88","author":"Raman","year":"1987","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000204725","article-title":"Acquired von Willebrand disease in association with essential thrombocythemia: regression following treatment","volume":"87","author":"Murakawa","year":"1992","journal-title":"Acta Haematologica"},{"key":"10.1053\/beha.2001.0141_RF127","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01698487","article-title":"Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia","volume":"69","author":"Van Genderen","year":"1994","journal-title":"Annals of Hematology"},{"key":"10.1053\/beha.2001.0141_RF128","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood.V68.6.1213.1213","article-title":"Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome","volume":"68","author":"Budde","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2141.1997.4823285.x","article-title":"Decreased half-life time of plasma von Willebrand factor collagen binding activity in essential thrombocythemia: normalization after cytoreduction of the increased platelet count","volume":"99","author":"Van Genderen","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.1984.tb02379.x","article-title":"Histopathology of erythromelalgia in thrombocythemia","volume":"8","author":"Michiels","year":"1984","journal-title":"Histopathology"},{"key":"10.1053\/beha.2001.0141_RF131","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-102-4-466","article-title":"Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia","volume":"102","author":"Michiels","year":"1985","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/beha.2001.0141_RF132","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1055\/s-2007-996111","article-title":"Aspirin in essential thrombocythemia: status quo and quo vadis","volume":"23","author":"Griesshammer","year":"1997","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF133","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-2007-996109","article-title":"Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera","volume":"23","author":"Van Genderen","year":"1997","journal-title":"Seminars in Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF134","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin","volume":"97","author":"Van Genderen","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0141_RF135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/107602969900500107","article-title":"Normal life expectancy and thrombosis-free survival in aspirin treated essential thrombocythemia","volume":"5","author":"Michiels","year":"1999","journal-title":"Clinical and Applied Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF136","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/107602969900500408","article-title":"Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia","volume":"5","author":"Michiels","year":"1999","journal-title":"Clinical and Applied Thrombosis and Hemostasis"},{"key":"10.1053\/beha.2001.0141_RF137","first-page":"73","article-title":"Erythromelalgic, thrombotic and hemorrhagic thrombocythemia","volume":"23","author":"Van Genderen","year":"1994","journal-title":"Presse M\u00e9dicale"},{"key":"10.1053\/beha.2001.0141_RF138","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.V15.5.706.706","article-title":"Hemorrhagic thrombocythemia. A critical review","volume":"15","author":"Gunz","year":"1960","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0141_RF139","first-page":"412","article-title":"Acquired Morbus von Willebrand","volume":"23","author":"Veltkamp","year":"1970","journal-title":"Thrombosis Diathesis Haemorrhagica"},{"key":"10.1053\/beha.2001.0141_RF140","first-page":"178","article-title":"Induction of von Willebrand disease type 1 by valproic acid","volume":"335","author":"Kruez","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0141_RF141","first-page":"143","article-title":"Acquired von Willebrand's disease, IgE polyclonal gammopathy and griseofulvin therapy","volume":"41","author":"Conrad","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF142","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajh.2830490114","article-title":"Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin","volume":"49","author":"Castaman","year":"1995","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0141_RF143","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1537-2995.1985.25385219904.x","article-title":"Hydroxyethyl starch accentuates von Willebrand's disease","volume":"25","author":"Strauss","year":"1985","journal-title":"Transfusion"},{"key":"10.1053\/beha.2001.0141_RF144","first-page":"306","article-title":"The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand factor: ristocetin cofactor activity","volume":"25","author":"Lazarchik","year":"1995","journal-title":"Annals of Clinical and Laboratory Science"},{"key":"10.1053\/beha.2001.0141_RF145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/ajcp\/88.5.653","article-title":"Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch","volume":"88","author":"Sanfelippo","year":"1987","journal-title":"American Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0141_RF146","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2044.1988.tb09021.x","article-title":"A severe coagulopathy following replacement with hydroxyethyl starch in a Jehovah's witness","volume":"43","author":"Lockwood","year":"1988","journal-title":"Anaesthesia"},{"key":"10.1053\/beha.2001.0141_RF147","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2257.1992.tb00367.x","article-title":"Hydroxyethyl starch induced acquired von Willebrand's disease","volume":"14","author":"Dalrymple-Hay","year":"1992","journal-title":"Clinical and Laboratory Haematology"},{"key":"10.1053\/beha.2001.0141_RF148","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1055\/s-0038-1657671","article-title":"Coagulation disorders caused by hydroxyethyl starch","volume":"78","author":"Treib","year":"1997","journal-title":"Thrombosis and Haemostasis"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T16:29:30Z","timestamp":1581006570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901410"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0141","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}